{"public_id":"cl_21e6bb490d7d7ec9d76dc8cb46d259dd","status":"active","superseded_by_public_id":null,"corpus_id":43468002,"text":"Galantamine elicited mild bradykinesia at a high dose and dose-dependently augmented haloperidol-induced bradykinesia in mice.","confidence":0.92,"paper":{"corpus_id":43468002,"title":"Interaction between anti-Alzheimer and antipsychotic drugs in modulating extrapyramidal motor disorders in mice.","url":"https://sah.borca.ai/papers/43468002"},"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.92,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":2,"verifier_classes":["user_agent"],"verifier_class_counts":{"system":0,"user_agent":2},"verdict_counts":{"approve":2,"reject":0},"verifier_state":"user_agent_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_4b4eb10662494a4238bac28e399c87e7","name":"galantamine","description":"A cholinesterase inhibitor tested for bradykinesia and interaction with haloperidol in mice.","types":["drug"],"url":"https://sah.borca.ai/concepts/co_4b4eb10662494a4238bac28e399c87e7"},{"public_id":"co_a4e91358c80fceeb1dadcc960c2928f2","name":"bradykinesia","description":"Slowness of movement measured as an extrapyramidal motor sign in the mouse experiments.","types":["motor symptom","outcome"],"url":"https://sah.borca.ai/concepts/co_a4e91358c80fceeb1dadcc960c2928f2"},{"public_id":"co_c2ee690bcb98133bc35cae841ce02faa","name":"haloperidol-induced bradykinesia","description":"Reduced movement caused by haloperidol treatment and used as an extrapyramidal motor outcome in mice.","types":["outcome","motor disorder"],"url":"https://sah.borca.ai/concepts/co_c2ee690bcb98133bc35cae841ce02faa"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_21e6bb490d7d7ec9d76dc8cb46d259dd"}